Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of precision small molecule medicines for central nervous system (CNS) disorders. Their RAP technology platform allows for targeted drug development that aims to reduce side effects associated with traditional neuroscience drugs.

Rapport Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of precision small molecule medicines for central nervous system (CNS) disorders. Their RAP technology platform allows for targeted drug development that aims to reduce side effects associated with traditional neuroscience drugs.